Research ArticleIntegrin-dependent neuroblastoma cell adhesion and migration on laminin is regulated by expression levels of two enzymes in the O-mannosyl-linked glycosylation pathway, PomGnT1 and GnT-Vb
Introduction
The genomic analysis of various neuronal disorders over the past few years has shed light on the critical functions of protein glycosylation during the development of the nervous system. Human congenital disorders such as Walker Warburg syndrome (WWS), muscle–eye–brain disease (MEB), and Fukuyama congenital muscular dystrophy (FCMD) are caused by inactivation of glycosyltransferases that function in the O-mannosyl glycan processing pathway [1], [2], [3], [4]. These disorders are characterized by muscular dystrophy with neuronal abnormalities. Particularly interesting are the defects in neuronal migration and nerve–muscle adhesion noted in muscle–eye–brain disease that are caused by inactivating mutations in the peptide-O-mannose β-1,2-acetylglucosminyltransferase known as PomGnT1 [3], the glycosyltransferase that transfers N-acetylglucosamine (GlcNAc) in beta(1,2) linkage onto Ser/Thr-O-mannosyl residues, allowing extension of O-mannosyl glycans. O-linked mannose structures comprise approximately 25% of the total O-linked glycans in brain [5]. These structures have been characterized from rabbit and sheep brain and partial structural information has been obtained for the J1 glycoprotein from the mouse nervous system [6], [7], [8], as well as alpha-dystroglycan in smooth muscle [9].
The glycosyltransferase termed GnT-Vb, also known as GnT-IX, is a recently discovered enzyme that is selectively expressed in neuronal cells and participates in the synthesis of O-mannosyl glycans [10], [11], [12], [13]. This enzyme catalyzes the transfer of GlcNAc in β(1,6) linkage to the peptide-O-linked-Man, but only if the β1,2-linked GlcNAc formed by PomGnT1 is present (Fig. 2A). Studies in vitro reveal that GnT-Vb prefers O-mannosyl acceptors, but can also transfer to the Man (β1,2)GlcNAc found in non-galactosylated N-linked glycans during biosynthesis [10]. However, its homolog, GnT-Va, is only capable of transferring GlcNAc in β(1,6) linkage to N-linked glycans. GnT-Vb activity is expected to be required for the expression of the majority of both O-linked polylactosamine and HNK-glycans in brain [10], both of which function in neuronal cell adhesion. Since GnT-Vb shows selective expression during neuromorphogenesis in the mouse (Matthews, unpublished data), it may function in neuronal cell adhesion and migration.
Neuroblastoma cells of the N-type (neuronal), such as SH-SY5Y, are typically loosely adherent to substrates, express neuronal cell surface markers, can be induced to differentiate, and are inherently tumorigenic in nude mice [14], [15], [16], [17]. In the present study, SH-SY5Y cells were used to study the potential role of GnT-Vb glycosylation in the regulation of cell adhesion, differentiation, and migration. We find that increased GnT-Vb expression leads to enhanced neurite outgrowth in SH-SY5Y cells plated on laminin. RNA interference studies show that reducing the expression levels of two glycosyltransferases acting in the O-mannosyl glycan pathway, GnT-Vb and POMGnT-I, using small interfering RNAs [18], leads to increased adhesion to laminin, as well as reduced migration, and impaired neurite outgrowth on this extracellular matrix glycoprotein. The phenotype observed in GnT-Vb suppressed cells could be rescued by expression of a form of GnT-Vb not targeted for RNA interference. We also show that suppression of GnT-Vb expression leads to significant changes in β1 integrin transcript and protein levels. Overall, these data indicate that GnT-Vb and PomGnT1 expression levels play an active role in modulating integrin and laminin-dependent adhesion and migration of human neuronal cells.
Section snippets
Antibodies and chemicals
ERK1/2 monoclonal antibody and all HRP-labeled anti-mouse and anti-rabbit IgG were obtained from Santa Cruz Biotechnology. Polyclonal antibody against β1 integrin was obtained from Chemicon. The HA epitope antibody was obtained from Roche. Laminin from human placenta was obtained from Sigma. All trans retinoic acid was obtained from Sigma. NHS-LC–biotin was a product of Pierce, and streptavidin–HRP was obtained from Vector Laboratory.
Plasmids
Targets for RNA interference were selected using the
GnT-Vb expression levels regulate neurite outgrowth of SH-SY5Y neuroblastoma cells
The SH-SY5Y cell line has been extensively used to study neuronal differentiation [20], [21], [22]. Notably, SH-SY5Y cells plated on laminin can be induced to differentiate and extend neurites by adding micromolar amounts of all trans retinoic acid (ATRA). To test if GnT-Vb-mediated glycosylation functions in human neuroblastoma cell differentiation in vitro, GnT-Vb was cloned into the expression vector pCDNA 3.1-HA and constitutively expressed in SH-SY5Y cells. There were no noticeable
Discussion
In this study, we demonstrate that the expression levels of GnT-Vb regulate neurite outgrowth, cell migration, and cell adhesion in the neuronal model SH-SY5Y neuroblastoma cells. The novel findings in this study include: (1) GnT-Vb expression increases retinoic acid-induced neurite outgrowth on laminin, while targeted RNA interference of GnT-Vb using 2 different targeting sequences reduces neurite outgrowth; (2) suppression of both GnT-Vb and PomGnT1, but not GnT-Va increases β1
Acknowledgments
We thank Dr. Steven K. Akiyama of NIEHS, National Institutes of Health, Research Triangle Park, NC, for the kind gift of function-blocking antibody against β1 integrin (mAb13); Dr. Huabei Guo for the technical help with the cell adhesion and migration assays; and Drs. Michael Tiemeyer and Rick Matthews for the excellent advice and editorial review.
References (49)
- et al.
Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1
Dev. Cell
(2001) - et al.
Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker–Warburg syndrome
Am. J. Hum. Genet.
(2002) - et al.
Brain contains HNK-1 immunoreactive O-glycans of the sulfoglucuronyl lactosamine series that terminate in 2-linked or 2,6-linked hexose (mannose)
J. Biol. Chem.
(1997) - et al.
Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain
J. Biol. Chem.
(1998) - et al.
Detection of O-mannosyl glycans in rabbit skeletal muscle alpha-dystroglycan
Biochim. Biophys. Acta
(1998) - et al.
N-acetylglucosaminyltransferase IX acts on the GlcNAc beta 1,2-Man alpha 1-Ser/Thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan
J. Biol. Chem.
(2004) - et al.
Molecular cloning and characterization of human GnT-IX, a novel beta1,6-N-acetylglucosaminyltransferase that is specifically expressed in the brain
J. Biol. Chem.
(2003) - et al.
A novel beta(1,6)-N-acetylglucosaminyltransferase V (GnT-VB)(1)
FEBS Lett.
(2003) - et al.
Recognition of oligosaccharide substrates by N-acetyl-glucosaminyltransferase-V
Carbohydr. Res.
(1988) - et al.
Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins
J. Biol. Chem.
(1982)
Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway
J. Biol. Chem.
High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas: involvement of its effect on apoptosis
FEBS Lett.
A genetic model for muscle–eye–brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1)
Mech Dev.
Neuronal laminins and their cellular receptors
Int. J. Biochem. Cell Biol.
alpha6beta1 integrin directs migration of neuronal precursors in adult mouse forebrain
Exp. Neurol.
N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell–cell adhesion and intracellular signaling pathways
J. Biol. Chem.
UDP-N-acetylglucosamine:alpha-6-d-mannoside beta1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice
Biochim. Biophys. Acta
Glycosylation profile of integrin alpha 3 beta 1 changes with melanoma progression
Biochim. Biophys. Acta
Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration
J. Biol. Chem.
A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering beta1 integrin sialylation
J. Biol. Chem.
Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins
Biochim. Biophys. Acta
Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors
Exp. Cell Res.
Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes
Cell
N-terminal alpha-dystroglycan binds to different extracellular matrix molecules expressed in regenerating peripheral nerves in a protein-mediated manner and promotes neurite extension of PC12 cells
Mol. Cell. Neurosci.
Cited by (30)
Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell–cell adhesion
2021, Journal of Biological ChemistryLoss of Mgat5a-mediated N-glycosylation stimulates regeneration in zebrafish
2016, Cell RegenerationMore than the genes, the tumor microenvironment in neuroblastoma
2016, Cancer LettersCitation Excerpt :Other integrins promote migration. This is the case of α3β1 and α1β1 integrins that interact with laminin promoting migration but also neurite outgrowth in the N-type SH-SY5Y human neuroblastoma cell line in a manner that is dependent on O-mannosyl-linked glycosylation events [98,99]. Binding of integrins to ECM proteins activates FAK and Src [100].
Glyco-genes change expression in cancer through aberrant methylation
2016, Biochimica et Biophysica Acta - General SubjectsGlycans and cancer: Role of N-Glycans in cancer biomarker, progression and metastasis, and therapeutics
2015, Advances in Cancer ResearchCitation Excerpt :Branched O-mannosyl glycans in the corpus callosum in the brain are involved in remyelination inhibition in the demyelination model, suggesting that the modulation of O-mannosyl glycan production is a potential candidate for therapeutic strategies against demyelinating diseases. It has been reported that the expression levels of GnT-IX modulate the integrin-dependent cell adhesion of neuroblastoma cells, and migration on laminin and integrin (Abbott, Troupe, Lee, & Pierce, 2006). The knockdown of GnT-IX in the study was likely related to O-mannosyl glycans because similar effects were also observed for the knockdown for POMGnT1.
Developmental expression of the neuron-specific N- acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in Vivo glycan products in comparison with those of its paralog, GnT-V
2012, Journal of Biological ChemistryCitation Excerpt :The timing and localization of GnT-Vb raise the possibility that it could also contribute to these disorders. Consistent with this hypothesis, we demonstrated previously that overexpression of GnT-Vb in a neuroblastoma cell line decreased adhesion to and increased motility on laminin (51). However, this study found no obvious changes in the migration or positioning of neurons in either GnT-Vb null or GnT-V/GnT-Vb double null brains.